Filana Therapeutics, Inc. Net Rentable Area
Filana Therapeutics, Inc. (FLNA) had Net Rentable Area of 6.00 thousand sqft as of 2018-12-31, per its 10-K filed 2019-03-29.
Discontinued › Notes
us-gaap:NetRentableArea · last filed 2019-03-29
- 2018-12-31: Net Rentable Area 6.00K sqft.
- 2017-12-31: Net Rentable Area 6.00K sqft.
- 2016-12-31: Net Rentable Area 6.00K sqft.
- 2015-12-31: Net Rentable Area 6.00K sqft.
| Period end | Net Rentable Area |
|---|---|
| 2018-12-31 | 6.00K sqft 10-K · filed 2019-03-29 |
| 2017-12-31 | 6.00K sqft 10-K · filed 2018-02-06 |
| 2016-12-31 | 6.00K sqft 10-K · filed 2017-03-07 |
| 2015-12-31 | 6.00K sqft 10-K · filed 2016-03-03 |
| 2014-12-31 | 6.00K sqft 10-K · filed 2015-02-18 |
| 2013-12-31 | 6.00K sqft 10-K · filed 2014-02-05 |
| 2013-06-30 | 6.00K sqft 10-Q · filed 2013-08-01 |
| 2013-03-31 | 6.00K sqft 10-Q · filed 2013-04-24 |
| 2012-12-31 | 6.00K sqft 10-K · filed 2013-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |